Literature DB >> 7731110

[A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].

M Kobayashi1, M Saito, S Minoshima, Y Arimura, T Nagasawa.   

Abstract

A 42-year-old female with progressive systemic sclerosis (PSS) developed rapidly progressive renal insufficiency. Renal pathology revealed crescentic glomerulonephritis (CrGN) without mucoid intimal proliferation of the interlobular arteries and fibrinoid necrosis of the afferent arterioles. Immunofluorescent micrography showed linear deposition of IgG along the glomerular capillary wall. Not only anti-glomerular basement membrane antibody (anti-GBM Ab), but also myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) were simultaneously detected by an enzymelinked immunosorbent assay (ELISA). She did not develop pulmonary hemorrhage. These findings were compatible with ANCA-related vasculitis and anti-GBM Ab nephritis. Laboratory findings showed rapid elevation of serum creatinine level (over 6.0mg/dl), a high titer of MPO-ANCA (660.7 ELISA unit/ml) and anti-GBM Ab (409 units). Therefore, she was started on methylprednisolone pulse therapy and temporary hemodialysis. After immunosuppressive therapy, both antibodies titers had fallen to within the normal range. However, end-stage renal failure did not improve and maintenance hemodialysis was introduced. Recently, six patients of PSS with MPO-ANCA were first reported in Japan. These autoantibodies detected in this case strongly suggested that there may be associations between anti-GBM Ab nephritis and ANCA-related vasculitis and PSS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731110

Source DB:  PubMed          Journal:  Nihon Jinzo Gakkai Shi        ISSN: 0385-2385


  7 in total

1.  Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases.

Authors:  Kimimasa Nakabayashi; Yasunori Fujioka; Toshihiko Nagasawa; Tsuneo Kimura; Kaoruko Kojima; Yoshihiro Arimura; Yasuhiro Arimura; Akira Yamada
Journal:  Clin Exp Nephrol       Date:  2011-01-20       Impact factor: 2.801

Review 2.  Scleroderma associated with ANCA-associated vasculitis.

Authors:  Young Hee Rho; Seong Jae Choi; Young Ho Lee; Jong Dae Ji; Gwan Gyu Song
Journal:  Rheumatol Int       Date:  2005-07-20       Impact factor: 2.631

3.  Acute renal failure in systemic sclerosis revealing Goodpasture syndrome: "All that glitters is not scleroderma renal crisis".

Authors:  Renaud Felten; Benoît Nespola; Emmanuel Chatelus; Laurent Arnaud; Jacques-Eric Gottenberg; Matthieu Canuet; Eric Prinz; Joëlle Goetz; Jean Sibilia
Journal:  J Scleroderma Relat Disord       Date:  2019-04-02

4.  Fever of unknown origin secondary to type I crescentic glomerulonephritis and anti-SCl 70 antibodies without clinical manifestations of systemic sclerosis.

Authors:  Jorge Vega Stieb; Helmuth Goecke Saavedra; Gonzalo Méndez Olivieri
Journal:  Clin Exp Nephrol       Date:  2008-05-20       Impact factor: 2.801

5.  Scleroderma with crescentic glomerulonephritis: a case report.

Authors:  Arunachalam Ramaswami; Thiraviam Kandaswamy; Tholappan Rajendran; Kizhake Pisharam Jeyakrishnan; Hla Aung; Mohammaed Iqbal; Chakko K Jacob; Haji Shaukat Zinna; Gazala Kafeel
Journal:  J Med Case Rep       Date:  2008-05-13

6.  Successful Treatment of Dual-Positive Anti-Myeloperoxidase and Anti-Glomerular Basement Membrane Antibody Vasculitis with Pulmonary-Renal Syndrome.

Authors:  Jinxian Huang; Ling Wu; Xiaoyan Huang; Yan Xie; Jinquan Yu; Jin Yang; Huiqiong Fang; Lijun Zhang
Journal:  Case Rep Nephrol Dial       Date:  2016-01-08

7.  Perinuclear Antineutrophil Cytoplasmic Antibody Positive Glomerulonephritis in a Case of Limited Cutaneous Scleroderma.

Authors:  H Vora; B Kulkarni; S Singh; N Kulkarni
Journal:  Indian J Nephrol       Date:  2018 May-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.